ARCHIVES

Clearinghouse Exec. Secty, Says It Has Failed in Its Objectives, Recommends It Be Dropped

This article is from The Cancer Letter archive.

Vol. 04 No. 02 | January 13, 1978

Download PDF Visit The Full Archive

Related Articles

Funding opportunities listed.

July 16, 2004

Ellence Has Lower Risk Of Heart Damage, Study Finds

August 27, 2004

Anidulafungin Safe And Well-Tolerated In Pediatric Patients With Neutropenia

November 26, 2004

In Brief: NCI’s John Czajkowski Takes Executive Dean Position At Harvard Medical School

February 21, 2014

Zerhouni Appoints Two Institute Directors

September 13, 2002

Gleevec Better Than Interferon For Newly Diagnosed CML

May 31, 2002